Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Rat (Rattus) Antibodies:
anti-Mouse (Murine) Antibodies:
Go to our pre-filtered search.
Cow (Bovine) Polyclonal CHRM4 Primary Antibody for IHC (p) - ABIN270800
Fong, Backman, Andersson, Scott, Danielson: Human tenocytes are stimulated to proliferate by acetylcholine through an EGFR signalling pathway. in Cell and tissue research 2013
the association of the African-specific CHRM4 SNP with cocaine dependence survived correction for multiple testing
This study demonstrated that CD4 (show CD4 Antibodies)+ and CD8 (show CD8A Antibodies)+ T cells expressed M2 and M4 muscarinic receptors which density were significantly increased in asthmatic children in comparison with controls.
[(3)H]LY2119620 to probe specifically the human M2 and M4 muscarinic receptor (show CHRM5 Antibodies) allosteric binding sites.
Data indicate that compounds derived from VU0152100 showed M4 muscarinic receptor (show CHRM5 Antibodies) (M4 mAChR (show CHRM3 Antibodies)) direct agoinst properties.
Use of HM4- and green fluorescent protein-expressing trangenic mice as tissue donors in cell-based therapy validates a rodent model of Huntington disease (show HTT Antibodies).
analysis of allosteric agonism and modulation at the M4 muscarinic acetylcholine receptor (show CHRNA1 Antibodies)
relative to other muscarinic receptor (show CHRM5 Antibodies) subtypes, the M(4) receptor could be the subtype which is selectively compromised in Alzeheimer's disease
M4 increases expression of "migratory" integrins; M4 effects resulted from inhibition of the inhibitory pathway involving the adenylyl cyclase-cyclic AMP (show APRT Antibodies)-protein kinase A pathway
In progressive supranuclear palsy: there were no changes in M4 muscarinic receptor (show CHRM5 Antibodies) density
The three receptor sets considered (mAChR (show CHRM3 Antibodies), AR and TrkB (show NTRK2 Antibodies) receptors) intervene in modulating the conditions of the competition between nerve endings.
In the present study, the functional coupling of Gi/o protein-coupled receptors to GalR1 (show GALR1 Antibodies), and the CB1 (show CNR1 Antibodies) receptor subtype for endocannabinoids were analyzed in the 3xTg-AD mice model of Alzheimer's disease in the prodromal and advanced stages. In addition, the activity mediated by Gi/o protein-coupled M2/4 (show GSDMD Antibodies) muscarinic receptor (show CHRM5 Antibodies) subtypes was also analyzed in brain areas involved in anxiety and cognition.
Muscarinic acetylcholine receptor (show CHRNB1 Antibodies) subtype 4 is essential for cholinergic stimulation of duodenal bicarbonate secretion in mice - relationship to D cell/somatostatin (show SST Antibodies)
We show that M4 is a major mAChR (show CHRM3 Antibodies) subtype mediating the cholinergic inhibition of corticostriatal glutamatergic input on both striatonigral and striatopallidal medium spiny neurons (MSNs).
Presence of M4 mAChR (show CHRM3 Antibodies) is sufficient and necessary to mediate the carbachol-induced membrane hyperpolarization and inhibition of SpECTs in laterodorsal tegmental nucleus neurons.
M4R is involved in regulation of locomotor activity, social behavior, and sensorimotor gating in mice.
Reducing M4 receptor signaling altered only select behavioral phenotypes in the Fmr1KO mouse model, suggesting that other targets are involved in the modulation of fragile X (show FMR1 Antibodies) behaviors.
Chrm4 receptor is located on presynaptic glutamatergic terminals afferent to the recorded pyramidal neuron, thus decreasing glutamate (show GRIN1 Antibodies) release.
Different coupling of striatal M(2)/M (show RPS26 Antibodies)(4)-mAChRs to the control of DA release in CPu versus NAc (show NLRP1 Antibodies) suggests targets to influence DA/ACh (show FGFR3 Antibodies) function differentially between striatal domains.
M(4) mAChR (show CHRM3 Antibodies) plays a central role in mediating cholinergic control of keratinocyte migration by endogenous acetylcholine produced by these cells
The muscarinic cholinergic receptors belong to a larger family of G protein-coupled receptors. The functional diversity of these receptors is defined by the binding of acetylcholine and includes cellular responses such as adenylate cyclase inhibition, phosphoinositide degeneration, and potassium channel mediation. Muscarinic receptors influence many effects of acetylcholine in the central and peripheral nervous system. The clinical implications of this receptor are unknown\; however, mouse studies link its function to adenylyl cyclase inhibition.
muscarinic acetylcholine receptor M4
, muscarinic acetylcholine receptor subtype 3
, cholinergic receptor, muscarinic 4
, cholinergic receptor, muscarin 4
, acetylcholine receptor, muscarinic 4
, AChR M4
, mm4 mAChR
, muscarinic acetylcholine receptor 4
, muscarinic receptor, M4 subtype
, Muscarinic acetylcholine receptor M4